IMPL

Impel Pharmaceuticals Inc. Common Stock

Delisted

IMPL was delisted on the 15th of December, 2023.

45 hedge funds and large institutions have $132M invested in Impel Pharmaceuticals Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 17 increasing their positions, 4 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$1.8M
2 +$1.23M
3 +$1.1M
4
DA
DCF Advisers
Connecticut
+$915K
5
BlackRock
BlackRock
New York
+$745K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$35.7M
2
$24.9M
3
$24.9M
4
$23.8M
5
$4.24M
6
$3.06M
7
$2.85M
8
$2.21M
9
$1.8M
10
$1.46M
11
$1.23M
12
$1.11M
13
$676K
14
$504K
15
$427K
16
$426K
17
$236K
18
$230K
19
$230K
20
$176K
21
$161K
22
$153K
23
$148K
24
$135K
25
$128K